Table 4.
Measured concentrations for each PM2.5-bound PAHs in inhaled air of individual (ng/m3) sorted by the sampling periods
| ng/m3 | LOQs | February–March 2019 (1st period)—ALL PARTICIPANTS | September–October 2019 (2nd period)—ALL PARTICIPANTS | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n = 133 | n = 126 | ||||||||||||||
| Positive samples (%) | Arithmetic mean | Median | 5th Percentile | 95th Percentile | MIN | MAX | Positive samples (%) | Arithmetic mean | Median | 5th Percentile | 95th Percentile | MIN | MAX | ||
| PHE | 0.050 | 51 | 0.075 | 0.052 | 0.025 | 0.228 | 0.051 | 0.725 | 68 | 0.173 | 0.113 | 0.025 | 0.505 | 0.052 | 0.622 |
| AN | 0.050 | 4 | - | - | - | - | 0.070 | 0.101 | 0 | n.d | n.d | - | - | ||
| FLA | 0.050 | 75 | 0.114 | 0.085 | 0.025 | 0.278 | 0.050 | 0.670 | 63 | 0.132 | 0.080 | 0.025 | 0.376 | 0.050 | 1.06 |
| PY | 0.050 | 86 | 0.163 | 0.131 | 0.025 | 0.415 | 0.050 | 0.993 | 71 | 0.203 | 0.095 | 0.025 | 0.476 | 0.052 | 3.18 |
| BcFL | 0.050 | 3 | - | - | - | - | 0.096 | 0.296 | 0 | n.d | n.d | - | - | - | - |
| BaA | 0.050 | 83 | 0.143 | 0.106 | 0.025 | 0.288 | 0.050 | 1.77 | 67 | 0.117 | 0.089 | 0.025 | 0.316 | 0.055 | 0.517 |
| CPP | 0.050 | 96 | 0.345 | 0.244 | 0.054 | 0.778 | 0.052 | 5.09 | 77 | 0.157 | 0.122 | 0.025 | 0.392 | 0.057 | 1.10 |
| CHR | 0.050 | 88 | 0.179 | 0.129 | 0.025 | 0.373 | 0.058 | 1.55 | 81 | 0.180 | 0.128 | 0.025 | 0.483 | 0.053 | 0.675 |
| 5MC | 0.050 | 0 | n.d | n.d | - | - | - | - | 0 | n.d | n.d | - | - | - | - |
| BbF | 0.050 | 96 | 0.343 | 0.256 | 0.077 | 0.748 | 0.069 | 4.38 | 97 | 0.357 | 0.274 | 0.061 | 0.979 | 0.052 | 1.38 |
| BkF | 0.050 | 83 | 0.170 | 0.120 | 0.025 | 0.383 | 0.053 | 2.72 | 75 | 0.171 | 0.130 | 0.025 | 0.476 | 0.050 | 0.699 |
| BjF | 0.050 | 86 | 0.188 | 0.130 | 0.025 | 0.421 | 0.051 | 2.53 | 80 | 0.248 | 0.185 | 0.025 | 0.627 | 0.053 | 0.954 |
| BaP | 0.050 | 97 | 0.321 | 0.231 | 0.078 | 0.752 | 0.057 | 5.18 | 96 | 0.378 | 0.274 | 0.053 | 0.976 | 0.050 | 1.67 |
| IP | 0.050 | 96 | 0.308 | 0.229 | 0.057 | 0.609 | 0.054 | 4.43 | 94 | 0.353 | 0.267 | 0.032 | 0.846 | 0.052 | 1.43 |
| DBahA | 0.050 | 18 | - | - | - | - | 0.055 | 1.27 | 53 | 0.082 | 0.060 | 0.025 | 0.213 | 0.051 | 0.369 |
| BghiP | 0.050 | 98 | 0.369 | 0.277 | 0.085 | 0.691 | 0.050 | 5.43 | 98 | 0.401 | 0.315 | 0.065 | 0.976 | 0.052 | 1.53 |
| DBaIP | 0.050 | 0 | n.d | n.d | - | - | - | - | 0 | n.d | n.d | - | - | - | - |
| DBaeP | 0.100 | 2 | - | - | - | - | 0.328 | 1.03 | 0 | n.d | n.d | - | - | - | - |
| DBaiP | 0.100 | 1 | - | - | - | - | 0.383 | 0.383 | 0 | n.d | n.d | - | - | - | - |
| DBahP | 0.100 | 0 | n.d | n.d | - | - | - | - | 0 | n.d | n.d | - | - | - | - |
Values are rounded to three significant figures and maximum three decimal places; LOQs limit of quantification; for results below LOQ and with more than 50% positive samples, a value ½ of LOQ was used for calculation of arithmetic mean, median, 5th and 95th percentile. Abbreviations of analytes: phenanthrene (PHE), anthracene (AN), fluoranthene (FLA), pyrene (PY), benzo[a]anthracene (BaA), chrysene (CHR), benzo[b]fluoranthene (BbF), benzo[k]fluoranthene (BkF), benzo[a]pyrene (BaP), dibenzo[a,h]anthracene (DBahA), indeno[1,2,3-cd]pyrene (IP), benzo[g,h,i]perylene (BghiP), benzo[c]fluorene (BcFL), cyclopenta[c,d]pyrene (CPP), 5-methylchrysene (5MCH), benzo[j]fluoranthene (BjF), dibenzo[a,l]pyrene (DBalP), dibenzo[a,e]pyrene (DBaeP), dibenzo[a,i]pyrene (DBaiP), dibenzo[a,h]pyrene (DBahP)